Advanced Medical Solutions Group Management
Management criteria checks 4/4
Advanced Medical Solutions Group's CEO is Chris Meredith, appointed in Jan 2011, has a tenure of 18.75 years. total yearly compensation is £813.00K, comprised of 46.6% salary and 53.4% bonuses, including company stock and options. directly owns 0.83% of the company’s shares, worth €4.33M. The average tenure of the management team and the board of directors is 5 years and 3.9 years respectively.
Key information
Chris Meredith
Chief executive officer
UK£813.0k
Total compensation
| CEO salary percentage | 46.6% |
| CEO tenure | 14yrs |
| CEO ownership | 0.8% |
| Management average tenure | 5yrs |
| Board average tenure | 3.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | UK£11m |
| Mar 31 2024 | n/a | n/a | UK£14m |
| Dec 31 2023 | UK£813k | UK£379k | UK£16m |
| Sep 30 2023 | n/a | n/a | UK£18m |
| Jun 30 2023 | n/a | n/a | UK£20m |
| Mar 31 2023 | n/a | n/a | UK£20m |
| Dec 31 2022 | UK£832k | UK£339k | UK£20m |
| Sep 30 2022 | n/a | n/a | UK£19m |
| Jun 30 2022 | n/a | n/a | UK£18m |
| Mar 31 2022 | n/a | n/a | UK£18m |
| Dec 31 2021 | UK£543k | UK£329k | UK£17m |
| Sep 30 2021 | n/a | n/a | UK£16m |
| Jun 30 2021 | n/a | n/a | UK£14m |
| Mar 31 2021 | n/a | n/a | UK£11m |
| Dec 31 2020 | UK£537k | UK£305k | UK£9m |
| Sep 30 2020 | n/a | n/a | UK£11m |
| Jun 30 2020 | n/a | n/a | UK£14m |
| Mar 31 2020 | n/a | n/a | UK£16m |
| Dec 31 2019 | UK£770k | UK£300k | UK£19m |
| Sep 30 2019 | n/a | n/a | UK£20m |
| Jun 30 2019 | n/a | n/a | UK£21m |
| Mar 31 2019 | n/a | n/a | UK£22m |
| Jan 01 2019 | n/a | n/a | UK£22m |
Compensation vs Market: Chris's total compensation ($USD1.01M) is about average for companies of similar size in the German market ($USD994.30K).
Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.
CEO
Chris Meredith (58 yo)
14yrs
Tenure
UK£813,000
Compensation
Mr. Andrew Christopher Meredith, also known as Chris, B.Sc. (Hons.) has been the Chief Executive Officer of Advanced Medical Solutions Group plc since January 2011 and served as Chief Operating Officer sin...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 14yrs | UK£813.00k | 0.83% € 4.3m | |
| CFO & Executive Director | 6yrs | UK£415.00k | 0.078% € 404.1k | |
| Group Operations Director | less than a year | no data | no data | |
| Investor Relations Manager | no data | no data | no data | |
| Head of Legal | no data | no data | no data | |
| Group Human Resources Director | 7.7yrs | no data | no data | |
| Chief Commercial Officer | less than a year | no data | no data | |
| Company Secretary | 4yrs | no data | no data |
5.0yrs
Average Tenure
Experienced Management: AQA's management team is seasoned and experienced (5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 18.8yrs | UK£813.00k | 0.83% € 4.3m | |
| CFO & Executive Director | 6yrs | UK£415.00k | 0.078% € 404.1k | |
| Senior Independent Non-Executive Director | 3.9yrs | UK£57.00k | no data | |
| Independent Non-Executive Director | 3.4yrs | UK£54.00k | no data | |
| Independent Non-Executive Chairman | 2.4yrs | UK£46.00k | 0.025% € 130.5k |
3.9yrs
Average Tenure
58yo
Average Age
Experienced Board: AQA's board of directors are considered experienced (3.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 16:03 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Advanced Medical Solutions Group plc is covered by 22 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Samuel England | Berenberg |
| Julie Simmonds | Canaccord Genuity |
| Keith Redpath | Cavendish |